Position in CCCC
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$537,633
-$91,247 QoQ
Shares Held
115,125
-51.9% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 147 holders
Holding Since
Dec 2021
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CCCC Over Time
Shares Held
Position Value (USD)
Derivatives in CCCC
reported options exposure · as of Jun 30, 2026CallValue
$1,401
CallShares
300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names. CCCC ranks #69 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
126,005 | $33,608,053 | |
| 2 | CYTK |
Cytokinetics Inc
|
239,728 | $20,422,428 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
288,233 | $16,492,692 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
386,183 | $14,393,040 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,596 | $14,089,509 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
334,854 | $11,180,775 | |
| 7 | TYRA |
Tyra Biosciences, Inc.
|
347,898 | $11,111,862 | |
| 8 | BCAX |
Bicara Therapeutics Inc.
|
353,226 | $10,487,279 |
All Filings in CCCC
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,401 | 300 | Call | Sole | 2026-08-03 | |
| 2026-06-30 | $537,633 | 115,125 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,052 | 400 | Call | Sole | 2026-05-13 | |
| 2026-03-31 | $628,880 | 239,118 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $47,559 | 24,900 | Call | Sole | 2026-02-13 | |
| 2025-12-31 | $573 | 300 | Put | Sole | 2026-02-13 | |
| 2025-12-31 | $846,781 | 443,341 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $54,390 | 24,500 | Call | Sole | 2025-11-14 | |
| 2024-12-31 | $146,948 | 40,819 | Shares | Sole | 2025-02-13 | |
| 2024-12-31 | $10,440 | 2,900 | Call | Sole | 2025-02-13 | |
| 2024-06-30 | $184,689 | 39,976 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $99,792 | 21,600 | Call | Sole | 2024-08-14 | |
| 2024-03-31 | $121,733 | 14,900 | Put | Sole | 2024-05-15 | |
| 2024-03-31 | $281,048 | 34,400 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $427,323 | 52,304 | Shares | Sole | 2024-05-15 | |
| 2023-03-31 | $93,546 | 29,792 | Shares | Sole | 2023-05-15 | |
| 2023-03-31 | $13,188 | 4,200 | Call | Sole | 2023-05-15 | |
| 2022-12-31 | $252,148 | 42,737 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $970,049 | 110,610 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,369,565 | 314,266 | Shares | Sole | 2022-08-19 | |
| 2021-12-31 | $2,631,384 | 81,720 | Shares | Sole | 2022-05-27 | |
| No filing history on record for this holder in this stock. | ||||||